Oslo Børs
Stockholmsbörsen
Københavns Fondsbørs
Investeringsforeninger
Helsingin pörssi
World Indices
US Stocks
US 30
Nasdaq 100
US 500
Toronto Stock Exchange
London Stock Exchange
Euronext Amsterdam
Euronext Brussel
DAX
SDAX
TECDAX
CDAX
MDAX
Prime Standard
CAC 40
Mumbai S.E.
National S.E.
Commodities
Currency
Cryptocurrency
Exchange Traded Funds
Investtech Indices
Lyxor MDAX (DR) UCITS (C007.ETF)
Close: 21.88 (+0.07), Dec 23, 2024
See Recommendation
Automatic technical analysis. Medium term, Dec 23, 2024
Lyxor MDAX (DR) UCITS ETF is in a falling trend channel in the medium long term. This shows that investors over time have sold at lower prices to get out of the ETF, and indicates negative development for the ETF. The price has reacted back after a break of the inverse head and shoulders formation without entirely reaching the objective at 24.00. A decisive break up through 22.34 will again give new positive signals to the ETF, while a break on the opposite side of the formation will be a strong negative signal. The ETF has broken down through support at euro 22.10. This predicts a further decline.Recommendation one to six months: See Recommendation
Partners
Investtech in the media
Digital Investor
Dagbladet
Hegnar
E24
Placera
How Investtech works
Collect stock market data
Price, volume, insider information, corporate actions etc.
Perform advanced analysis
Using mathematical pattern recognition, statistical optimization and behavioural finance
Deliver actionable insights
Daily across the stocks, indices and commodities that matter most to your portfolio
Investtech by the numbers
Experience
21years
since 1997
Model portfolio
14.5%
average annual return
Analysis across
20+
stock exchanges
Recommendations of
30 000+
stocks, indices, currencies, cryptocurrencies and commodities
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Head office
Strandveien 171366 Lysaker, Norway
Research department
Instituttveien 102007 Kjeller, Norway
+47 21 555 888
Contact us
×
